Where to start
These guides sit next to the GLP-1 tracker, the dose / units helper, and brand logs for Ozempic, Wegovy, Mounjaro, and Zepbound. See everything Vialie records on the track index.
Private vs. cloud GLP-1 trackers: what actually leaves your phone
What "local-only" actually means, what a cloud tracker sends and to whom, and six questions to ask before you log a first entry.
Read the post →PeptidesHow to log peptides safely: a track-only approach to recording vials
A record structure for peptide vials that stays track-only: label, vial, site, and outcome, without becoming a protocol or a dosing guide.
Read the post →GLP-1GLP-1 pen inventory: how to stop running out mid-week
Why a GLP-1 refill runs out at the worst time, and the three-field inventory habit that stops it from happening again.
Read the post →GLP-1GLP-1 reminders that actually work: setting a schedule you control
Why generic daily reminders get ignored, and how to set a weekly GLP-1 reminder that fires once, on your schedule, and stops when confirmed.
Read the post →GuidesWhat to bring to your GLP-1 or peptide appointment
What a clinician can actually use from your record, and how to turn a month of entries into a PDF or CSV worth bringing to an appointment.
Read the post →PeptidesPeptide vial storage and expiry: what to record, not what to do
Why storage and expiry instructions should come from the label or clinic, and what to record so that information stays with the vial, not just in memory.
Read the post →GuidesCustom labels: tracking a peptide or supplement no app recognizes
What to do when a peptide, supplement, or compounded label is not in an app’s built-in list, and why a custom label should record exactly the same way as a recognised one.
Read the post →GLP-1How to log GLP-1 side effects for your clinician
A simple structure for logging GLP-1 side effects next to your dose history, built for a clinician to read, not to decide anything for you.
Read the post →VialieVialie vs. Vially vs. Vialy: which app is which
A factual, non-smear comparison of Vialie, Vially, Vialy, and Vial: Peptide Tracker, so you confirm which app you actually meant to open.
Read the post →CaregivingKeeping a caregiver medication log with Friend View
How to use Friend View to keep a separate, private caregiver log - doses, symptoms, notes - without mixing it into your own timeline.
Read the post →GLP-1How to log a missed or late GLP-1 dose for your clinician
What to write down after a missed or late GLP-1 dose so your clinician can see the gap, where the actual answer comes from, and how to export it.
Read the post →GLP-1GLP-1 injection site rotation: a simple log, not a recommendation
A simple field-by-field structure for logging which GLP-1 injection site you used each time, so rotation is a glance instead of a guess.
Read the post →ComparisonBest private iPhone GLP-1 tracker for on-device logs
A direct answer for a private on-device iPhone GLP-1 log, plus criteria for TrackPep, Titra, and GLP AI. No download counts and no number-one rank.
Read the post →PrivacyA private GLP-1 tracker that does not need an account
What works with no account, buying and restoring Plus with your Apple ID, optional iCloud sync, and what Delete local data removes.
Read the post →PeptidesHow to keep a GHK-Cu and copper peptide log
A track-only record for GHK-Cu and copper peptides: label, route, batch, photos, and notes, with no protocol or effect claims.
Read the post →GLP-1How to log weight and photos next to a GLP-1 record
Keep weight entries and optional progress photos on the same private timeline as your GLP-1 doses, without turning the journal into coaching.
Read the post →PrivacyVialie vs other private GLP-1 trackers: what to compare
A facts table of Vialie’s own answers: account, sync, exports, Friend View, and look-alike names, to compare with any other GLP-1 app.
Read the post →PrivacyWhat a local-only peptide tracker on iPhone actually means
On-device storage vs a device backup vs a company cloud: three different promises for a peptide log on iPhone, and which one Vialie makes.
Read the post →ResearchGLP-1 statistics (2026): how many people use them, what it costs them, and why people stop
How many US adults take GLP-1 medicines, how many stop within a year and why, and the FDA shortage and compounding numbers. Every figure is linked to its primary source.
Read the post →